Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people on Mounjaro lose weight from the first month, but the pace varies more than the trial headlines suggest. If you want to lose weight more quickly on Mounjaro, the research points to a handful of practical factors — protein intake, activity, hydration, and how well you work with the medicine's appetite-reducing effect — rather than anything dramatic. Mounjaro (tirzepatide) is a prescription-only medicine and your prescriber sets your dose; no two treatment plans are identical. What this page covers is the evidence-backed context around those factors, so you can have a more useful conversation with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is one of the most common things people raise with clinical teams. Mounjaro's starting dose of 2.5mg is a tolerability step; its job is to let your body adjust to tirzepatide, not to produce immediate large losses. Many people see modest movement in weeks one to four, then noticeably more as the dose increases. If the scale seems stuck, it is worth asking whether what you're eating has actually changed, or whether reduced nausea has led you back to higher-calorie habits without realising it.
The NHS notes that tirzepatide works best alongside a reduced-calorie diet and increased physical activity, this isn't fine print. The medicine narrows your appetite window, but it does not decide what fills that window. People who use the early weeks to build a routine around higher-protein, lower-processed-food eating tend to report steadier losses as doses increase. A useful reference on the basics of supporting weight loss alongside medication is the NHS Better Health guidance on healthy weight. Separately, if you want a clearer picture of what typical timelines look like, the overview of how quickly weight loss happens on Mounjaro sets out the evidence by dose phase.
One practical note: people who eat their last meal earlier in the evening and keep breakfast protein-rich tend to find the midday appetite suppression more useful. Small structural choices compound over months.
The paradox of appetite suppression is that it can make it easy to under-eat in ways that backfire. If you regularly skip meals or consume very little, your body adapts by slowing the rate at which it burns energy, the opposite of what you want. Lean muscle is expensive tissue metabolically; protecting it speeds up fat loss relative to overall weight lost.
Prioritising protein at every meal you do eat is the single most evidence-supported dietary move on any GLP-1 medicine. Eggs, chicken, fish, Greek yoghurt, lentils and cottage cheese all count. Fibre matters too: it slows digestion, feeds gut bacteria, and helps manage the constipation that some people notice, particularly in the first few months. Both nutrients are far more satiating per calorie than refined carbohydrates, so a smaller meal can still feel like enough.
If you want detailed, personalised guidance on eating patterns during treatment, a registered dietitian is the right person to consult. Our prescribers can flag this as part of your review. The guide to losing weight on Mounjaro covers the dietary side in more depth if you'd like a fuller read before your next check-in.
Physical activity on tirzepatide isn't just about burning more calories, it changes what you lose. In clinical studies, participants who combined GLP-1 treatment with resistance exercise preserved significantly more muscle mass than those who relied on diet alone. More muscle means a higher resting metabolic rate, which matters enormously for long-term weight management after treatment eventually ends.
You don't need a gym membership. Bodyweight exercises (squats, press-ups, resistance bands) done three times a week are enough to send the preservation signal. Walking briskly for 30 minutes daily adds meaningfully to total energy expenditure without stressing joints. If you've been largely sedentary, start there. The goal in the first two months is consistency over intensity.
One thing worth knowing: some people notice they feel the effects of alcohol more quickly during treatment. There's a practical reason for that, and it's worth understanding how Mounjaro affects alcohol tolerance before any social occasions involving drinking. It is tangentially related to gastric emptying, which the medicine slows.
For the cost context around treatment, the Mounjaro cost page sets out what private treatment typically involves, including what a single transparent price covers.
Poor sleep is one of the most underappreciated barriers to weight loss on any medicine. When sleep is consistently short or broken, cortisol rises and appetite-regulating hormones shift in a direction that works against tirzepatide rather than with it. You may find the medicine's suppression effect feels weaker on nights after poor sleep, particularly around the third or fourth day before your next injection. This is reported often enough that it is worth taking seriously, even if the clinical evidence is still building.
Chronic stress has a parallel effect. It drives cortisol, which promotes fat storage around the abdomen specifically. If your life circumstances make stress reduction difficult right now, that is worth naming with your prescriber so the overall picture of your progress is interpreted correctly, a plateau during a high-stress period isn't a failure of the medicine.
The SURMOUNT-1 trial published in the New England Journal of Medicine reported average weight reductions of around 20–21% at the highest tirzepatide dose over 72 weeks, an important benchmark, but one that reflects populations under trial conditions with full dietary and behavioural support. Real-world results cluster around that figure for people who engage actively. The full detail of tirzepatide's evidence base, including what influenced outcomes in SURMOUNT-1, is explained on the tirzepatide overview.
If you're on Mounjaro privately and wondering whether your current dose and progress are on track, the prescribers at nume carry out a clinical review before every repeat, not just at the start. That ongoing oversight is where questions like these belong. If you're also using minoxidil alongside your treatment, the guidance on combining minoxidil and Mounjaro is worth reading before your next check-in. When you're ready to speak to our prescribers, the consultation is free and reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.